Indication
Allogeneic Hematopoietic Cell Transplantation
5 clinical trials
4 products
1 drug
Clinical trial
Safety and Efficacy of TCRαβ+/CD19+ Depleted Allogeneic Hematopoietic Stem Cell Transplantation for Malignant and Non-malignant Disorders in Children and Adolescent/Young Adult PatientsStatus: Terminated, Estimated PCD: 2021-05-14
Clinical trial
A Randomized Placebo-Controlled Clinical Trial of Fecal Microbiota Transplantation in Patients With Acute Myeloid Leukemia and Allogeneic Hematopoietic Cell Transplantation RecipientsStatus: Completed, Estimated PCD: 2022-02-11
Product
Fecal Microbiota TransplantClinical trial
Healthcare Associated Infection Reduction in Stem Cell Transplant Patients: a Randomized, Double-blind, Placebo-controlled Study Evaluating Twice Daily Xylitol AdministrationStatus: Terminated, Estimated PCD: 2021-03-20
Product
XylitolClinical trial
Precision Alemtuzumab Dosing for Allogeneic Hematopoietic Cell Transplantation in Non-Malignant DiseasesStatus: Recruiting, Estimated PCD: 2028-08-31
Drug
alemtuzumabClinical trial
A Pilot Study of Nicotinamide Riboside Supplementation in Allogeneic Hematopoietic Cell TransplantationStatus: Recruiting, Estimated PCD: 2024-10-01
Product
Nicotinamide riboside